Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ETON
ETON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ETON News
Eton Pharmaceuticals Secures U.S. Rights for Hemangeol Commercialization
6d ago
NASDAQ.COM
Eton Pharmaceuticals to Report Q4 and Full Year 2025 Financial Results
6d ago
Newsfilter
Eton Secures U.S. Commercialization Rights for HEMANGEOL®
Mar 02 2026
Newsfilter
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
Eton Pharmaceuticals' DESMODA Receives FDA Approval
Feb 26 2026
NASDAQ.COM
Eton Pharmaceuticals Receives FDA Approval for New Drug Launch
Feb 25 2026
seekingalpha
Eton's DESMODA Receives FDA Approval for Central Diabetes Insipidus
Feb 25 2026
Newsfilter
FDA Approves Zycubo for Pediatric Menkes Disease Treatment
Jan 28 2026
NASDAQ.COM
Eton Pharmaceuticals to Host Investor Meeting at Piper Sandler Healthcare Conference in NYC
Nov 24 2025
Newsfilter
Eton Pharmaceuticals to Attend the 16th Annual Craig-Hallum Alpha Select Conference on November 18th
Nov 12 2025
Newsfilter
Eton Pharma (ETON) Third Quarter 2025 Earnings Call Transcript
Nov 09 2025
NASDAQ.COM
Eton Pharmaceuticals Stock Options Experience a Surge in Implied Volatility
Sep 22 2025
NASDAQ.COM
Eton Pharmaceuticals to Attend the 2025 Wells Fargo Healthcare Conference
Aug 20 2025
Newsfilter
FDA Accepts Eton Pharma's NDA For ET-600 Desmopressin Oral Solution
Jul 08 2025
NASDAQ.COM
Eton gains as hormonal disorder therapy undergoes FDA review
Jul 08 2025
SeekingAlpha
Eton Pharmaceuticals Added to Russell 3000® and Russell 2000® Indexes as Part of 2025 Reconstitution
Jun 27 2025
NASDAQ.COM
Show More News
